Some members were asking if this was going to be available and here it is.
CLL Support’s inaugural webinar began with an update by Chairman Marc Auckland. The main talk was given by Peter Hillmen, Consultant in Clinical Haematology at Leeds Teaching Hospitals NHS Trust. Peter began by summarising CLL and discusses what treatments and trials were available pre-Covid. Peter then goes on to discuss how Covid-19 has affected hosptials. Finally Peter covers the issues of shielding, risks and immunity before answering questions. The last talk in the webinar was CLL patient Paul’s lockdown story. Questions that were not answered on the day can be found below, together with answers.
cllsupport.org.uk/conferenc...
For anyone who is not a member of UK CLL Support here is the latest Newsletter. Membership if free so why not join?
images.cllsupport.org.uk/wp...
Jackie
ASH 2018: Professor Peter Hillmen on the Combination of Ibrutinib and Obinutuzumab in CLL: Timing Matters
